
Images are for product identification. Refer to the selected batch for packaging and availability.
Nikoran Iv 48/2ml
Drug Formula unavailable
YOUR PURCHASE PRICE
13 in stockInclusive of all taxes
Available batch
1 offerSign in to order for your pharmacy.
Product information
- Manufacturer
- Torrent Pharma (forza)
- Category
- Allopathy
- Composition
- Not provided
- Packaging
- 20 ML
- Box / case pack
- 1 / —
Description
NIKORAN IV 48/2ML by TORRENT PHARMA (FORZA)
NIKORAN IV 48/2ML is an intravenous medication manufactured by Torrent Pharmaceuticals Ltd.
-
Composition: Each lyophilized vial contains Nicorandil I.P. 48 mg. Nicorandil is a potassium channel opener and nitric oxide donor.
-
Uses:
- Primarily used for the prevention and treatment of heart-related chest pain (angina), particularly unstable angina.
- It is prescribed when other antianginal medications, such as beta-blockers or calcium antagonists, are not suitable or have been ineffective.
- Nicorandil works by relaxing and widening blood vessels, including the coronary arteries, which increases blood and oxygen supply to the heart and reduces its workload, thereby alleviating angina symptoms.
-
Dosage and Administration:
- NIKORAN IV is for intravenous infusion only and must be administered under the strict supervision of a healthcare professional; self-administration is not advised.
- The usual starting dosage for intravenous drip infusion is 2 mg per hour, not exceeding 6 mg per hour.
- The vial contents should be dissolved in physiological saline or 5% glucose solution and used within 24 hours. It should not be administered simultaneously with other intravenous solutions through the same line.
- Treatment may continue for 24 to 48 hours, often followed by a transition to oral nicorandil as directed by a doctor.
-
Side Effects:
- Common side effects include headache (especially at the start of treatment), dizziness, weakness, nausea, vomiting, palpitations, and flushing (a sense of warmth in the face, ears, neck, and trunk).
- Other reported effects include ulceration (mouth, gastric, skin), decreased blood pressure, increased heart rate, and fatigue.
-
Precautions:
- Contraindicated in patients with serious hepatic or renal dysfunction, severe hypotension, cardiogenic shock, and those taking phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil) or riociguat, due to the risk of dangerously low blood pressure.
- Blood pressure and hemodynamics should be monitored frequently during administration.
- Alcohol consumption is unsafe with NIKORAN IV as it may increase dizziness and potentiate blood pressure lowering effects.
- Use during pregnancy and breastfeeding is generally not recommended; consult a doctor.
- Due to potential dizziness or sleepiness, patients should avoid driving or operating machinery until they know how the medicine affects them.
- Avoid concurrent use with aspirin due to increased risk of gastrointestinal ulcers or bleeding.
-
Storage:
- Store in a refrigerator at 2°C to 8°C. Do not freeze.
- Alternatively, store below 25°C, away from direct sunlight and moisture, in its original packaging.
- Any unused portion after opening should be discarded immediately.
- Keep out of reach of children.
Frequently asked questions
NIKORAN IV 48/2ML by TORRENT PHARMA (FORZA) is an injectable medication containing Nicorandil, primarily used in the management of certain heart conditions.
What is NIKORAN IV used for?
NIKORAN IV is primarily used to prevent and manage angina pectoris, a type of chest pain caused by insufficient blood flow to the heart. It is indicated for the management of unstable angina and stable angina when other medications are ineffective or contraindicated. It is also used to improve microvascular function and left ventricular ejection fraction in patients with acute myocardial infarction.
How does NIKORAN IV work?
NIKORAN IV (Nicorandil) has a dual mechanism of action. It acts as a potassium channel opener and a nitrate donor. As a potassium channel opener, it causes vascular smooth muscle cells to hyperpolarize, leading to relaxation and widening of both coronary and peripheral resistance vessels, which reduces the heart's afterload. Additionally, its nitrate-like effect increases intracellular cyclic GMP, resulting in both venous and arterial dilation, which decreases the heart's preload. These actions collectively improve blood flow to the heart muscle and reduce its workload.
What is the usual dosage of NIKORAN IV?
NIKORAN IV is administered via intravenous infusion under the supervision of a qualified doctor in a clinical setting. The usual starting dosage for intravenous drip infusion is 2 mg per hour, and it should not exceed 6 mg per hour. The dose and rate of infusion are determined by the doctor based on the patient's condition and response to treatment. Infusion may continue for 24 to 48 hours, often followed by a transition to oral nicorandil.
What are the possible side effects of NIKORAN IV?
Common side effects of NIKORAN IV include headache, dizziness, weakness, flushing (redness of the skin), nausea, vomiting, and palpitations. More serious, though less frequent, side effects can include gastric or duodenal ulceration (painful sores in the stomach or small intestine), a significant decrease in blood pressure (hypotension), and an increase in heart rate. If you experience severe or persistent side effects, or notice blood in your stool or vomit, it is crucial to inform your doctor immediately.
Is NIKORAN IV safe during pregnancy or breastfeeding?
NIKORAN IV is generally not recommended during pregnancy as there is limited data on its safety and effects on the developing fetus. Animal studies have shown some adverse effects, so it should only be used if considered essential by the physician and if the potential benefits outweigh the risks.
For breastfeeding mothers, NIKORAN IV is also generally not recommended. It is not known how much nicorandil passes into breast milk or if it could harm a nursing infant. It is advisable to discuss with your doctor if you are breastfeeding or planning to breastfeed.
Can NIKORAN IV be taken with other medications?
NIKORAN IV can interact with several medications. Concomitant use with phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) or soluble guanylate cyclase stimulators (e.g., riociguat) is contraindicated due to the risk of a severe and potentially dangerous drop in blood pressure.
Caution is advised when taken with:
- Corticosteroids or NSAIDs (like aspirin): May increase the risk of stomach ulcers or gastrointestinal bleeding.
- Antihypertensive drugs, other vasodilators, or tricyclic antidepressants: May potentiate the blood pressure-lowering effect.
- Medicines that increase potassium levels (e.g., ACE inhibitors, ARBs): May lead to hyperkalemia (high potassium levels).
Always inform your doctor about all medications, vitamins, and herbal supplements you are taking to avoid potential interactions.
What precautions should be taken with NIKORAN IV?
Several precautions should be observed when using NIKORAN IV:
- Blood Pressure Monitoring: Blood pressure and hemodynamics should be frequently monitored during administration, and the dose should be adjusted gradually based on the patient's status.
- Hypotension: Use with caution in patients with low systolic blood pressure (e.g., below 100 mm Hg) as it can further lower blood pressure. It is contraindicated in severe hypotension or cardiogenic shock.
- Liver and Kidney Impairment: Use cautiously in patients with severe liver impairment. Dose adjustment or close monitoring may be required in patients with severe renal impairment.
- Ulceration: There is a risk of gastrointestinal, skin, mucosal, corneal, and conjunctival ulcerations.
- Alcohol: Avoid consuming alcohol, as it can intensify the blood pressure-lowering effect and cause dizziness.
- Driving and Operating Machinery: NIKORAN IV may cause dizziness or weakness. Patients should be cautious if driving or operating machinery until they know how the medicine affects them.
- Contraindications: It is contraindicated in patients with severe hepatic or renal dysfunction, cerebral dysfunction, Eisenmenger's syndrome, primary pulmonary hypertension, right ventricular infarction, or a history of hypersensitivity to nicorandil or related compounds.
What happens if a dose of NIKORAN IV is missed?
Since NIKORAN IV is administered as an intravenous infusion in a clinical setting by a healthcare professional, missing a dose is unlikely. If there are concerns about the administration schedule, a healthcare professional should be consulted immediately.
How should NIKORAN IV be stored?
NIKORAN IV injection vials contain lyophilized Nicorandil, which needs to be dissolved in physiological saline or 5% glucose solution before infusion. The prepared solution should be used within 24 hours of preparation. It should not be administered simultaneously with other IV solutions through the same line. Specific storage conditions for the unopened vial would typically be found on the product packaging, but general drug storage guidelines suggest keeping medicines at room temperature, away from light and moisture, unless otherwise specified.